GOSS vs KMB · rev $26.2M vs P/E 19, rev $8.35B
Gossamer Bio Inc (GOSS) versus Kimberly-Clark Corporation (KMB) — a side-by-side from cached financials, not a winner call.
Gossamer Bio Inc (GOSS) is a biotechnology company listed on US.
Kimberly-Clark Corporation (KMB) is a household & personal products company listed on US.
Latest reported GOSS revenue for 2026-06-30 was $26.2M. Net income was -$29.8M. Revenue was up 54.5% from 2026-03-31 to 2026-06-30. GOSS currently screens at market cap $47.0M.
Latest reported KMB revenue for 2026-06-30 was $8.35B. Net income was $1.01B. KMB currently screens at market cap $32.88B and trailing P/E 19.2.
GOSS currently screens at market cap $47.0M. KMB currently screens at market cap $32.88B and trailing P/E 19.2.
Not investment advice. Open the GOSS and KMB stock pages for the full models.
Not investment advice.